Center-Authored Papers

Filters: Author is Herold, Betsy C  [Clear All Filters]
2011
Dezzutti CS, Hendrix CW, Marrazzo JM, Pan Z, Wang L, Louissaint N, Kalyoussef S, Torres MN, Hladik F, Parikh U et al..  2011.  Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators.. PloS one. 6(8):e23136. Abstract
Scott ME, Wilson SS, Cosentino LA, Richardson BA, Moscicki A-B, Hillier SL, Herold BC.  2011.  Interlaboratory reproducibility of female genital tract cytokine measurements by Luminex: implications for microbicide safety studies.. Cytokine. 56(2):430-4. Abstract
2012
Madan RP, Carpenter C, Fiedler T, Kalyoussef S, McAndrew TC, Viswanathan S, Kim M, Keller MJ, Fredricks DN, Herold BC.  2012.  Altered biomarkers of mucosal immunity and reduced vaginal lactobacillus concentrations in sexually active female adolescents.. PloS one. 7(7):e40415. Abstract
Kalyoussef S, Nieves E, Dinerman E, Carpenter C, Shankar V, Oh J, Burd B, Angeletti RH, Buckheit KW, Fredricks DN et al..  2012.  Lactobacillus proteins are associated with the bactericidal activity against E. coli of female genital tract secretions.. PloS one. 7(11):e49506. Abstract
Keller MJ, Carpenter CA, Lo Y, Einstein MH, Liu C, Fredricks DN, Herold BC.  2012.  Phase I randomized safety study of twice daily dosing of acidform vaginal gel: candidate antimicrobial contraceptive.. PloS one. 7(10):e46901. Abstract
Dezzutti CS, Richardson BA, Marrazzo JM, Tugetman J, Ramjee G, Taha T, Chirenje ZM, Abdool Karim SS, Hillier SL, Herold BC.  2012.  Mucosal Escherichia coli Bactericidal Activity and Immune Mediators Are Associated With HIV-1 Seroconversion in Women Participating in the HPTN 035 Trial.. The Journal of infectious diseases. 206(12):1931-5. Abstract
Keller MJ, Madan RP, Shust G, Carpenter CA, Torres MN, Cho S, Khine H, Huang M-L, Corey L, Kim M et al..  2012.  Changes in the Soluble Mucosal Immune Environment during Genital Herpes Outbreaks.. Journal of acquired immune deficiency syndromes (1999). 61(2):194-202. Abstract
2014
Herold BC, Dezzutti CS, Richardson BA, Marrazzo J, Mesquita PMM, Carpenter C, Huber A, Louissaint N, Marzinke MA, Hillier SL et al..  2014.  Antiviral Activity of Genital Tract Secretions following Oral or Topical Tenofovir Pre-exposure Prophylaxis for HIV-1.. Journal of acquired immune deficiency syndromes (1999). Abstract
2015
Murphy K, Richardson BA, Dezzutti CS, Marrazzo J, Hillier SL, Hendrix CW, Herold BC.  2015.  Levels of Genital Tract Defensins and Cytokines Differ between HIV-Uninfected US and African Women.. American journal of reproductive immunology (New York, N.Y. : 1989). Abstract
Madan RP, Dezzutti CS, Rabe L, Hillier SL, Marrazzo J, McGowan I, Richardson BA, Herold BC.  2015.  Soluble Immune Mediators and Vaginal Bacteria Impact Innate Genital Mucosal Antimicrobial Activity in Young Women.. American journal of reproductive immunology (New York, N.Y. : 1989). Abstract
Keller MJ, Mesquita PM, Marzinke MA, Teller R, Espinoza L, Atrio JM, Lo Y, Frank B, Srinivasan S, Fredricks DN et al..  2015.  A phase 1 randomized placebo-controlled safety and pharmacokinetic trial of a tenofovir disoproxil fumarate vaginal ring.. AIDS (London, England). Abstract